Fuad El-Hibri, Director at Aptevo Therapeutics Inc. (APVO), bought 100,000 shares at $0.76 ($76K) on 2019-08-12, disclosed to the SEC on 2019-08-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |